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It has been proved that inhibition of protein kinase C by 1-(5-isoquinolinylsulfonyl)-I-methylpiperazine (H7)induces morphological differentiation 
in murine neuroblastoma (nb) cell. Here we report that H7 is also active on human nb cell lines. The human nb cell had originally neuroblast-like 
(N) or intermediate (I) morphology. N and I type are thought to represent different stages of neuroblastoma differentiation. Neurite outgrowth 
was observed in both N and I type morphology treating the cells with 7, 14 or 28 PM of H7. The results confirm previous observations and show 
that inhibition of PKC by H7 also promotes neuronal differentiation in human cell line variants. 
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1. INTRODUCTION 
Neuroblastoma cells can be induced to differentiate 
in vitro using natural or chemical agents [l-4]. Neural 
cell differentiation is accompanied by outgrowth of 
neurite-like structures which form a complex network. 
Recently, Minana et al. [5] reported that murine 
neuro-2a cells can be fully differentiated in the presence 
of 1-(5isoquinolinylsulfonyl)-2-methylpiperazine (H7), 
a specific inhibitor of protein kinase C (PKC). They 
suggest a role of PKC in the control of neural differen- 
tiation. 
Here, we report our experience concerning the treat- 
ment with H7 of three human neuroblastoma cell lines 
showing neuroblast (N) or intermediate (I) morphology 
[6]. Neurites were detected either in N and I type cells. 
This observation extends knowledge obtained from 
previous results [5,7] on the role of PKC in 
neuroblastoma cell differentiation and shows that 
specific inhibition of PKC produces neurite outgrowth 
of diverse human neuroblastoma cell variants. 
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2. MATERIALS AND METHODS 
2.1. Neuroblastoma cell lines 
SK-N-BEZ(C), I-type; Lan-1 and Lan-5, N-type neuroblastoma 
cells (kindly provided by V. Ciccarone, NCI, Frederick) were 
cultured as previously described [2]. 
2.2. Treatment of the cells with H7 
Dose-response curve was assessed using the following final concen- 
trations of H7: 3.5, 7, 14 and 28 pM dissolved in ethanol and added 
to the culture at time: 0,48 and 96 h. Control cells were treated with 
ethanol. Every 48 h the medium was changed and H7 added again. 
Cell viability was checked by the Trypan blue exclusion test. Neurite 
formation was observed by phase contrast light microscope and 
photographed. 
3. RESULTS AND DISCUSSION 
Neurite outgrowth accompanied by clear mor- 
phological differentiation was observed in human 
neuroblastoma cell lines SK-N-BE(2)C, Lan-1 and 
Lan-5 treated with 28 /cM H7. Fig. 1 shows the mor- 
phology of the cells after 7 days of treatment with 
28 PM of H7. Dose-response curve (data not shown) in- 
dicated that Lan-1 cells were more sensitive to H7 ac- 
tivity (7 PM was sufficient to produce neurites) than 
SK-N-BE(2)C which needed 28 PM (Table I). At a con- 
centration of 28 PM, H7 induced morphological dif- 
ferentiation of all three cell lines irrespective of their 
basal morphology, neuroblast- or intermediate-type. 
N-type cell is small, round and presents some neurite- 
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Fig. 1. Neurite outgrowth and morphological differentiation of human neuroblastoma cell variants treated with 28 ,uM of H7. LAN-l medium 
(A), H7 (B); LAN-5 medium (C), H7 (D), both cell lines are N-type morphology. SK-N-BE(2)C medium (E), H7 (F), I-type morphology. The 
cells were photographed with a phase contrast light microscope after 7 days of culture. 
Table I 
Dose-dependent H7 activity on the human neuroblastoma cell 
variants 
Cell line H7 GM) 
3.5 7 14 28 
SK-N-BE(Z) _* +/- + 
LAN-l - + + ++ 
LAN-S ND ND ++ ++ 
* Neurite outgrowth: - , no neurite formation; + / - , appreciable 
neurite outgrowth; + , ex-novo neurite formation protruding from 
several cells; + +, evident neurite outgrowth from many cells 
forming neurite network; and ND, not detected 
like processes. This morphological type contains the 
neurofilaments [8] and appears related to neuronal cell 
with properties of noradrenergic neurons. I-type cell is 
morphologically intermediate between two cell types: 
N, described above and epithelial-like (S) cells with pro- 
perties of melanocyte and Schwann cells, and contain- 
ing the intermediate filament-related protein vimentin 
[%W. 
Our results show that H7 induces neuritogenesis in 
human neuroblastoma cells as well as in murine cells. 
Since H7 is a specific inhibitor of PKC, it appears that 
inhibition of PKC activity is involved in the mor- 
phological differentiation of the neuroblast. 
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Minana et al. [5], treating the neuro-2a cells with 85 
and 5OO/rM H7 observed over 60% of the cells with 
neurites. We detected morphological differentiation at 
concentrations of H7 ranging between 7 and 28 ,QM 
showing that H7 is more effective on human cells. 
Taken as a whole, the results indicate that PKC is in- 
volved in morphological differentiation and neurite 
outgrowth of both murine and human neuroblastoma 
cells. In our hands, H7 induced cell differentiation in 
both neuroblast and intermediate cell types. 
Since N- and I-type cell variants are thought to be 
associated at distinct stages of neuronal development 
[ll], H7 appears generally active on neuroblastoma 
cells having different morphological and biochemical 
characteristics. 
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